Dudediligence.

Lexeo Therapeutics, Inc

LXEONASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,082,037

26 notices · 183,861 sh

Oct 2025 to Oct 2026

Reported ·

$685,183

20 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

1 of 20 reported sales carry the 10b5-1 box. Together they are 0.12% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-18: Townsend Richard Nolan, Form 1442026-08-18: Otero Jose Manuel, Form 1442026-08-18: Tamayo Louis Edward, Form 1442026-07-01: Otero Jose Manuel, Form 1442026-07-01: Tamayo Louis Edward, Form 1442026-07-01: Bhalla Narinder Pal, Form 1442026-07-01: Townsend Richard Nolan, Form 1442026-05-18: Townsend Richard Nolan, Form 1442026-05-18: Otero Jose Manuel, Form 1442026-05-18: Adler Eric, Form 1442026-04-06: Richard Nolan Townsend, Form 1442026-02-18: Townsend Richard Nolan, Form 1442026-02-18: Otero Jose Manuel, Form 1442026-02-18: See Tai Sandi, Form 1442026-02-18: Robertson Jenny, Form 1442026-02-18: Adler Eric, Form 1442025-11-18: Robertson Jenny, Form 1442025-11-18: See Tai Sandi, Form 1442025-11-18: Otero Jose Manuel, Form 1442025-11-18: Adler Eric, Form 1442025-11-18: Townsend Richard Nolan, Form 1442025-10-17: Adler Eric, Form 1442025-10-17: Otero Jose Manuel, Form 1442025-10-17: Robertson Jenny, Form 1442025-10-17: Townsend Richard Nolan, Form 1442025-10-17: See Tai Sandi, Form 1442025-10-17: Adler Eric, sold2025-10-17: Robertson Jenny, sold2025-10-17: Townsend Richard Nolan, sold2025-10-17: See Tai Sandi, sold2025-10-17: Otero Jose Manuel, sold2025-11-18: Adler Eric, sold2025-11-18: Robertson Jenny, sold2025-11-18: Townsend Richard Nolan, sold2025-11-18: See Tai Sandi, sold2025-11-18: Otero Jose Manuel, sold2026-02-18: Townsend Richard Nolan, sold2026-02-18: Otero Jose Manuel, sold2026-04-06: Townsend Richard Nolan, sold2026-05-18: Townsend Richard Nolan, sold2026-05-18: Otero Jose Manuel, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-18Townsend Richard Nolan, Chief Executive Officer$16,562
3,345 shplan 2025-11-13Form 4s on file end Jun 23144 ↗
2026-08-18Otero Jose Manuel, Chief Operating Officer$6,464
1,304 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-18Tamayo Louis Edward, Chief Financial Officer$20,203
4,117 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-01Otero Jose Manuel, Chief Operating Officer$20,919
4,666 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-01Tamayo Louis Edward, Chief Financial Officer$20,815
4,641 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-01Bhalla Narinder Pal, Chief Medical Officer$98,684
22,306 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-01Townsend Richard Nolan, Chief Executive Officer$116,185
25,947 shplan 2025-11-13Form 4s on file end Jun 23144 ↗
2026-05-18Townsend Richard Nolan, Chief Executive Officer$16,927
3,342 shplan 2025-11-13144 ↗
Form 4, 2026-05-20: sold 3,342 at $5.06 Form 4 ↗
2026-05-18Otero Jose Manuel, Chief Operating Officer$6,606
1,302 shno plan date144 ↗
Form 4, 2026-05-20: sold 1,302 at $5.07 Form 4 ↗
2026-05-18Adler Eric, Chief Medical Officer$8,074
1,595 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-06Richard Nolan Townsend, Chief Executive Officer$314,600
55,000 shplan 2025-11-13144 ↗
Form 4, 2026-04-07: sold 55,000 at $5.69 Form 4 ↗
2026-02-18Townsend Richard Nolan, Chief Executive Officer$72,585
11,374 shplan 2025-11-13144 ↗
Form 4, 2026-02-20: sold 10,173 at $6.38 Form 4 ↗
2026-02-18Otero Jose Manuel, Chief Operating Officer$19,294
3,016 shno plan date144 ↗
Form 4, 2026-02-20: sold 3,016 at $6.40 Form 4 ↗
2026-02-18See Tai Sandi, Chief Development Officer$24,684
3,861 shno plan dateno Form 4 on file144 ↗
2026-02-18Robertson Jenny, Chief Legal Officer$23,897
3,736 shno plan dateno Form 4 on file144 ↗
2026-02-18Adler Eric, Chief Medical Officer$31,135
4,867 shno plan dateno Form 4 on file144 ↗
2025-11-18Robertson Jenny, Chief Legal Officer$5,092
549 shno plan date144 ↗
Form 4, 2025-11-20: sold 549 at $9.27 Form 4 ↗
2025-11-18See Tai Sandi, Chief Development Officer$3,580
386 shno plan date144 ↗
Form 4, 2025-11-20: sold 386 at $9.27 Form 4 ↗
2025-11-18Otero Jose Manuel, Chief Operating Officer$6,687
721 shno plan date144 ↗
Form 4, 2026-02-20: sold 721 at $9.27 Form 4 ↗
2025-11-18Adler Eric, Chief Medical Officer$5,704
615 shno plan date144 ↗
Form 4, 2025-11-20: sold 615 at $9.27 Form 4 ↗
2025-11-18Townsend Richard Nolan, Chief Executive Officer$10,452
1,127 shplan 2025-11-13144 ↗
Form 4, 2025-11-20: sold 1,127 at $9.27 Form 4 ↗
2025-10-17Adler Eric, Chief Medical Officer$30,242
3,382 shno plan date144 ↗
Form 4, 2025-10-17: sold 3,382 at $8.95 Form 4 ↗
2025-10-17Otero Jose Manuel, Chief Operating Officer$18,913
2,115 shno plan date144 ↗
Form 4, 2025-10-17: sold 2,115 at $8.95 Form 4 ↗
2025-10-17Robertson Jenny, Chief Legal Officer$31,530
3,526 shno plan date144 ↗
Form 4, 2025-10-17: sold 3,526 at $8.95 Form 4 ↗
2025-10-17Townsend Richard Nolan, Chief Executive Officer$117,437
13,133 shno plan date144 ↗
Form 4, 2025-10-17: sold 13,133 at $8.95 Form 4 ↗
2025-10-17See Tai Sandi, Chief Development Officer$34,767
3,888 shno plan date144 ↗
Form 4, 2025-10-17: sold 3,888 at $8.95 Form 4 ↗